General Hospital of Eastern Theater Command

Nanjing, Jiangsu 210002

0 studies enrolling now · 3 studies all time

What they study most

Hepatocellular Carcinoma (HCC), NSCLC, Non-Small-Cell Lung Cancer, Ulcerative Colitis

Studies at this site

• Lorlatinib Continuation Study — Running, not enrolling
• ABTECT-1 - ABX464 Treatment Evaluation for Ulcerative Colitis Therapy -1 — Completed
• A Study of Tislelizumab Versus Sorafenib in Participants With Unresectable Hepatocellular Carcinoma (HCC) — Completed